Subissi A, Brunori P, Bachi M
Eur J Pharmacol. 1983 Dec 23;96(3-4):295-301. doi: 10.1016/0014-2999(83)90320-5.
Eight spasmolytic drugs commonly used in the treatment of the irritable bowel syndrome were compared to verapamil with respect to their effects (all drugs injected i.v.) on the contraction of duodenum, ileum and colon induced by high K+ topical application in the anaesthetized rat. Verapamil greater than rociverine greater than papaverine greater than mebeverine greater than dicyclomine antagonized dose-dependently the contraction of duodenum and colon, the activity on duodenum being from 2 (rociverine) to 10 (verapamil) fold higher. Verapamil and rociverine, but not the other drugs mentioned above, were also active on ileum. N-Butylscopolammonium bromide, phloroglucinol and trimebutine were inactive against the contraction of the three intestinal tracts and prifinium bromide was inactive on duodenum and ileum, while it had remarkable activity on colon, unrelated to its antimuscarinic activity. The results are discussed briefly with reference to the pharmacological therapy of the irritable bowel syndrome.
将用于治疗肠易激综合征的八种解痉药物与维拉帕米进行比较,观察它们(所有药物均静脉注射)对麻醉大鼠十二指肠、回肠和结肠高钾局部应用所诱导收缩的影响。维拉帕米>罗西维林>罂粟碱>美贝维林>双环维林对十二指肠和结肠的收缩具有剂量依赖性拮抗作用,对十二指肠的活性比罗西维林高2倍(罗西维林)至10倍(维拉帕米)。维拉帕米和罗西维林,但不是上述其他药物,对回肠也有活性。溴化N-丁基东莨菪碱、间苯三酚和曲美布汀对三个肠道的收缩无活性,溴化丙胺太林对十二指肠和回肠无活性,而对结肠有显著活性,与其抗毒蕈碱活性无关。结合肠易激综合征的药物治疗简要讨论了结果。